Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
F. Morin
Observed name:
F Morin
Institution:
Intergroupe Francophone de Cancérologie Thoracique
Observed institutions:
Université Sorbonne Paris Nord,
Intergroupe Francophone de Cancérologie Thoracique,
Centre Hospitalier Universitaire de Caen Normandie,
Centre Hospitalier Universitaire de Clermont-Ferrand,
Hôpital Tenon
ORCID:
0009-0004-6018-1170
Observed ORCID:
0009-0004-6018-1170
OpenAlex ID:
A5020726369
Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study
2025
·
M. Wislez
, C. Mascaux
, et al.
·
European Journal of Cancer
·
16
PDF
IFCT-1502 CLINIVO: Real-life experience with nivolumab in 600 patients (pts) with advanced non-small cell lung cancer (NSCLC): Efficacy and safety of nivolumab and post-nivolumab treatment in the French Expanded Access Program (EAP)
2017
·
N. Girard
, C. Audigier Valette
, et al.
·
Annals of Oncology
·
12
PDF
Evaluation of class III beta-tubulin (bTubIII) expression as a prognostic marker in patients with resectable non-small cell lung cancer (NSCLC) treated by perioperative chemotherapy (CT) in the phase III trial IFCT-0002
2009
·
G. Zalcman
, G. Levallet
, et al.
·
Journal of Clinical Oncology
·
11
IFCT0002 phase III study comparing a preoperative (PRE) and a perioperative (PERI) chemotherapy with two different CT regimens in resectable non-small cell lung cancer (NSCLC): Early results
2007
·
B. Milleron
, E. Quoix
, et al.
·
Journal of Clinical Oncology
·
3
3128 EGFR, ALK, KRAS prognostic value in a large French prospective cohort of non-previously treated advanced NSCLC. Preliminary report of the IFCT-PREDICT.amm cohort
2015
·
J. Cadranel
, E. Quoix
, et al.
·
European Journal of Cancer
·
2
Use of a three-microRNA signature to discriminate prognostic groups in early-stage NSCLC patients in the IFCT-0002 trial.
2011
·
C. Mascaux
, G. Levallet
, et al.
·
Journal of Clinical Oncology
·
2
IFCT-0504 trial: Mucinous (M) and nonmucinous (NM) cytologic subtypes interaction effect in first-line treatment of advanced bronchioloalveolar carcinoma (BAC) by erlotinib (E) or carboplatin/paclitaxel (C/P).
2011
·
J. Cadranel
, R. Gervais
, et al.
·
Journal of Clinical Oncology
·
2
Pcn81 Cost-effectiveness Analysis of Three Strategies of Erlotinib Treatment in Non0-small-cell Lung Cancer:a Prospective Multicentric French Study (ermetic)
2010
·
I Borget
, J Cadranel
, et al.
·
Value in Health
·
1
PDF
1987MO Efficacy of lorlatinib after failure of a first-line ROS1 tyrosine kinase inhibitor (ROS1 TKI) in patients (pts) with advanced ROS1-positive non-small cell lung cancer (ROS1+ NSCLC) (IFCT-2003 ALBATROS)
2025
·
M. Duruisseaux
, C. Ardin
, et al.
·
Annals of Oncology
401P: Access to molecular testing for lung cancer in France: A national cross-sectional survey of routine practices
2025
·
A. Bayle
, F. Erdogan
, et al.
·
Journal of Thoracic Oncology
PDF
1239 Microcosting evaluation of prognostic/predictive biomarkers performed in a large French prospective cohort of non previously treated advanced NSCLC. Preliminary report of the IFCT-PREDICT.amm cohort
2015
·
S. Loubiere
, M. Wislez
, et al.
·
European Journal of Cancer
Mutations rares des exons 18 et 20 de l’EGFR dans les cancers bronchiques non à petites cellules chez 10 117 patients : étude observationnelle multicentrique du réseau ERMETIC de l’IFCT
2014
·
N. Prim
, M. Beau-Faller
, et al.
·
Revue des Maladies Respiratoires
Pcn97 Cost Effectiveness of Erlotinib Treatment Given by a Clinically Based Approach and an Egfr/kras Testing-guided Approach Advanced in Non Small-cell Lung Cancer: a Prospective Multicentric French Study (ermetic)
2009
·
I Borget
, J Cadranel
, et al.
·
Value in Health
PDF
[French clinical research in thoracic oncology].
2004
·
F Morin
·
PubMed
Gemcitabine (G), Ifosfamide (I), Vinorelbine (N) in advanced non-small cell lung cancer (NSCLC): A phase II study
2004
·
J. F. Morère
, M. C. Pailler
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
15
Citation count:
56
H-index:
4
I10-index:
3
Year
Topic
Type